Chinese startup Gestala, focused on non-invasive ultrasound-based brain-computer interface (BCI) technology, has successfully raised $21.6 million in funding just two months after its launch. This funding round, co-led by Guosheng Capital and Dalton Venture, marks a significant milestone for the Chinese BCI industry.
Founder and CEO Phoenix Peng stated that the investment will support Gestala’s research and development efforts, team expansion, and the establishment of a manufacturing facility in China. The startup aims to grow its team from 15 to 35 employees by the end of the year and plans to unveil its first-generation prototype by year-end.
Gestala’s focus on non-invasive ultrasound technology sets it apart in the BCI sector, offering potential advantages in terms of safety and accessibility compared to implanted electrode systems. By leveraging phased-array ultrasound, the technology can provide broader brain access and enable new ways to interact with neural activity.
This influx of funding highlights the growing interest and investment in ultrasound BCI technology globally. While companies like Neuralink and Merge Labs are leading efforts in the U.S., Gestala’s emergence in China marks a significant step in advancing BCI capabilities.
Source: TechCrunch